×
Thursday, November 19, 2026

"FCA Qui Tam Litigation After Zafirov: What the Eleventh Circuit's Ruling Means for Healthcare and Government Contractors," Health Law Pulse, Davis Wright Tremaine Webinar - Davis Wright Tremaine

The False Claims Act (FCA) remains the federal government's primary tool for combating fraud, generating billions of dollars in recoveries each year. Recent constitutional challenges, however, have raised fundamental questions about whether private whistleblowers, known as relators, can continue to bring FCA claims on behalf of the United States.

In a closely watched decision, the Eleventh Circuit reversed a district court ruling that had declared the FCA's qui tam provisions unconstitutional under the Appointments Clause. While the ruling preserves the current FCA enforcement framework, significant questions remain, including the possibility of Supreme Court review.

Join DWT partner Ross Siler for a discussion of the Eleventh Circuit's decision, the constitutional arguments shaping FCA litigation, and the practical implications for healthcare providers, life sciences companies, government contractors, and other regulated organizations. Viewers will gain insight into emerging litigation trends, enforcement risks, and key developments to watch in the months ahead.

Webinar Transcript

Ross Siler: Well, thanks for joining. I hope you are having a good pre-Thanksgiving week. I'm excited to give this presentation today. It's one that I've wanted to do for a long time. I really was waiting for the Eleventh Circuit to rule in the Zafroff case that we'll talk about for a year plus, before I could give this presentation, and the Eleventh Circuit issued its opinion on September 1st,...



Read Full Story: https://news.google.com/rss/articles/CBMifkFVX3lxTE5Rb1NlYmpEVzJibGt4QTlDczhG...